This article provides a brief account of the history of the development of training opportunities in clinical research in the United States. It highlights some developments in the clinical research enterprise since World War II and focuses examination on the involvement of the U.S. government and academic sector. Clinical research training is a relatively new academic field, and curricula in the design and conduct of clinical research have only emerged since the 1980s. The growing complexity of clinical trials and the emergence of evidence-based medicine in the last several decades Dr. Teo is resident physician,
created great demand for clinicians with knowledge of clinical epidemiology and biostatistics. Amidst alarm bells rung by physician-scientist leaders about the endangered species of clinical researchers, numerous proposals and solutions emerged to address these workforce and educational problems in the 1990s. Traditionally, physicians wishing to expand their education had to get a master's degree in public health or participate in unique programs such as the Robert Wood Johnson Clinical Scholars Program. Since the 1990s, the National Institutes of Health, through K awards, the Roadmap Initiative, and other funding mechanisms, has furnished tremendous support for the development of clinical research training opportunities from predoctoral immersion programs to degree-granting graduate programs. The author discusses key components of successful clinical research training programs and concludes with empirical recommendations for promoting careers in clinical research. Acad Med. 2009; 84:433-438.
Editor's Note: Commentaries on this article appear on pages 409 and 411.
Thedemandfortrainingintheconduct of clinical research can be traced back to the increasing complexity and sophistication of medical research design after World War II. One of the earliest large-scale randomized controlled trials (RCTs) was the Salk polio vaccine field trial of 1954. Landmark cardiovascular studies initiated in the late 1970s and early 1980s such as the Hypertension Detection and Follow-up Program Cooperative Group 1 and the Physician Health Study 2 further helped establish RCTs as a highly effective method for clinical research. List 1 shows a timeline of some of the key events in the evolution and development of clinical research training in the United States. The term "clinical research," for the purposes of this article, refers to the National Institutes of Health (NIH) definition, which encompasses patient-oriented research, epidemiological and behavioral studies, and outcomes and health services research. 3 As the complexity (e.g., RCTs and metaanalyses) and scale (e.g., multicenter trials) of clinical research have grown, so has the technical expertise necessary to execute it. Human participants, trials involving healthy individuals, and involvement of pharmaceutical companies are examples of thorny issues that require conduct of the highest ethical standard. Data manipulation requires a mastery of difficult mathematical concepts in statistics and facility with software to analyze raw data. Writing skills, too, are indispensable in securing funding from grants and institutional review board approval of research protocols. The result is a diverse skill set too difficult to master without formalized curriculum and training.
With the increased focus on RCTs and clinical research, clinical epidemiology, described as the "basic science" 4 of clinical medicine, and biostatistics started to move from a peripheral intellectual field to an important presence within medical schools and an indispensable ally in modern clinical medicine. David Sackett founded Canada's first department of clinical epidemiology and biostatistics in 1967 at McMaster University, and he published a seminal article introducing the concept of clinical epidemiology two years later. 5 Public health schools, which also taught the topics, became more linked to medical schools.
Sackett and his colleagues at McMaster
University also receive credit for starting the global evidence-based medicine (EBM) movement by making available reliable information on therapies to all clinicians. It was not until 1992, however, that the term "evidence-based medicine" was first widely disseminated in another seminal article that described it as a "new paradigm in medical practice." 6 Medical school and residency programs nowadays include EBM to varying degrees in their curricula. 7, 8 
Tackling a Crisis in the Clinical Research Workforce
By the 1980s, a number of eminent research-oriented physicians publicly warned about an impending shortage of clinical researchers. James Wyngaarden, 9 then at Duke University but later head of the NIH, rang the first warning bell in 1979. Using a series of line graphs depicting the decline in NIH grants and fellowships awarded to MD investigators in contrast to the steady rise among PhD investigators, he famously heralded the clinical investigator an "endangered species." Wyngaarden and other doctors were particularly concerned about the lack of physician-scientists pursuing research that directly involved patients and that could be applied to improving care for their diseases. They suggested that the problem was not so much a lack of interest in clinical research per se but, rather, competition with careers in booming areas of basic science such as molecular biology. 10 The 1990s saw more detailed analyses of the problem. Edward Ahrens, 11 for one, produced a 200-page book. He was particularly concerned about a gap in the spectrum from basic bench research to applied clinical research, the area of "basic patient-oriented research" that investigates topics such as physiology and the fundamental mechanisms of human disease. Major national organizations like the Institute of Medicine, the NIH, and the Association of American Medical Colleges (AAMC) followed suit with reports focused on clinical research. The Institute of Medicine estimated that just 10% of NIH research at the time was clinical in nature. 12 In 1995, Harold Varmus, then head of the NIH, formed a special blue ribbon panel that released the so-called "Nathan Report" two years later. This report was instrumental in fostering more clinical research by offering a series of key, concrete recommendations. 13 Among them was the recommendation for awards that would support the development of clinical research training curriculum, realized in 1999 with the introduction of K30 awards. And, the AAMC, though slower in response, issued its own report delineating nine core problems and recommendations, including a specific call for formalized training programs. 14 Medical specialties, spurred by NIH recommendations, funded clinical research training grants for junior faculty motivated by an academic career in clinical investigation. 15 Concerned about the rapid decline in the number of clinical investigators, a group of physician-scientists committed to seeing medical science advanced by the active participation of real patients and bedside observations by such clinical investigators formed the Association for Patient-Oriented Research in the late 1990s. 16 An important backdrop to these increases in funding for clinical research training was the general increase in funding for medical research. From 1998 to 2003, the NIH underwent a boom in funding, thanks to political support, and its annual budget doubled from $14 to $28 billion. 17 This allowed the NIH to provide funding mechanisms such as the K awards that have been essential in encouraging the development of clinical investigators. Most K awards provide salary support to clinical investigators so that they can devote themselves to research, a critical concept called "protected time." The K23, K24, K08, and K12 awards, for instance, are specifically for those pursuing clinical research careers. The A "build it and they will come" mentality is insufficient, though, to ensure that young clinicians pursue careers in clinical research. To avoid another workforce crisis like that observed in the 1980s, I have assembled a series of eight recommendations along with their theoretical justifications (List 4). It is worth mentioning that the very rigorous evidence basis that is so central to contemporary clinical research is difficult to apply to measures to enhance clinical research training and careers. The limited studies of the impact of programs have tended to be either of qualitative descriptions of what graduates have done 20, 28 or of programs that failed to find a conclusive benefit. 15 One of the most methodologically rigorous studies demonstrated a static number of physicians applying for first major research grant (R01) from the NIH during 40 years, suggesting no increase in new physicians pursuing clinical research careers 27 ; however, the impact of reforms beginning in the late 1990s may not have been observed by 2004 when the study data ended. What these recommendations do represent is a synthesis of empirical strategies that have been used with anecdotal success.
Looking Toward the Future
The NIH again served as the key impetus for change in 2002 when Director Elias Concerns over the balance between basic and clinical research will doubtless continue in the future. In particular, the subgroup of clinical investigators that is specifically patient oriented as opposed to laboratory based remains an endangered species because of a dearth of funding opportunities. Nonetheless, it is amazing to consider that in the span of little more than two decades, the United States has gone from experts decrying the state of the clinical research enterprise and a few scattered offerings to a nationwide network of institutions, programs, and funding for education in how to conduct clinical research. It is exciting to consider what the next development will be and the impact of training programs in the coming years. Unfortunately, we live in an era in which imaging and laboratory testing have taken priority over a thorough history and physical exam. A renowned professor in cardiology once looked at the book that I was reading and told me, "Stop wasting your time; just do an MRI." The book was one of my favorites: Localization in Clinical Neurology. He smiled; I didn't smile back. I did not think it was funny. But it helped me understand why, during my internship, my residents were often intrigued when they saw me walk with a patient. Even though this aspect of the physical exam is simple and routine, I noticed that it was often overlooked, which would sometimes result in unfortunate events. Two interactions from my rotation in neurology consults illustrate my concerns:
A 45-year-old man was admitted for urinary tract infection. It was his third episode within three years. He had had dysuria for those three years and was being treated for benign prostatic hypertrophy. He also had a spastic walk that had never been addressed. Physical exam showed upper motor neuron disease in his lower extremities with a T10-level sensation. A spine MRI revealed a T8 -T9 herniated disc compressing the spinal cord. After spine surgery, the patient's symptoms, including his dysuria, resolved.
A 70-year-old woman with mild dementia was hospitalized for pneumonia. She was ambulatory upon admission. Her stay was complicated by hypertension that was aggressively treated. She remained in bed for the total length of stay. Upon discharge, she couldn't walk. Investigation showed that she had had a subacute stroke during her stay.
A focused physical assessment is more efficient than a complete evaluation, particularly for chronic patients. However, omitting certain aspects of the physical exam can sometimes lead to serious consequences. True, time is lacking, and we are always in a rush, but that should not compromise our patients' safety. Solid assessments and wise use of available resources-ones as simple as focused attention to physical assessments-are what make medicine an art. Walk with your patients. They will heal quicker.
